Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Intervención de Salud Oral en Pacientes en Hemodiálisis

9 de noviembre de 2026 actualizado por: Sevda Ateş, Çanakkale Onsekiz Mart University

El efecto de la educación sobre higiene bucal y las tarjetas recordatorias en pacientes que reciben tratamiento de hemodiálisis: un estudio cuasi-experimental

Preserving dental health in patients undergoing hemodialysis is crucial for enhancing quality of life. Nonetheless, interventions pertaining to oral health have not been adequately studied. The impact of a simultaneous intervention comprising oral health education and reminder cards remains ambiguous. The findings help to examine the effect of oral health interventions on the levels of oral health and chronic disease adherence in patients receiving hemodialysis treatment. The use of oral care education, reminder cards, and checklists related to oral health can prevent the neglect of oral care.

Descripción general del estudio

Descripción detallada

Preserving dental health in patients undergoing hemodialysis is crucial for enhancing quality of life. Nonetheless, interventions pertaining to oral health have not been adequately studied. The aim is to investigate the impact of oral care education and reminder cards concerning oral health on the oral health and illness adaptation of persons undergoing hemodialysis. The study employed a quasi-experimental design with a single group, utilising pre-test and post-test measurements. The study included 82 individuals (aged ≥ 18 years) receiving treatment in the hemodialysis units of two different hospitals in Turkey. Sociodemographic and clinical information was obtained from medical records. The "Adaptation to Chronic Illness Scale" and the "Oral Assessment Guide" were employed to assess oral health and illness adaptation. A one-week intervention was conducted, using daily oral health reminder cards following oral care teaching. A significant difference was found between the mean oral health and illness adaptation levels in the pre-test (15.51±2.67; 84.37±9.14, respectively) and post-test (12.61±3.83; 86.26±9.66, respectively) scores (p=0.00). Oral health and treatment adherence were better after the use of oral care education and reminder cards (p=0.00). Daily tooth brushing frequency was a common factor influencing oral health and chronic disease adherence levels (p<0.05). The mean scores for oral health and illness adaptation were moderately and negatively correlated before and after the intervention (sırasıyla r=-0.46, r=-0.52; p<0.01). The findings help to examine the effect of oral health interventions on the levels of oral health and chronic disease adherence in patients receiving hemodialysis treatment. The use of oral care education, reminder cards, and checklists related to oral health can prevent the neglect of oral care.

Tipo de estudio

De observación

Inscripción (Actual)

82

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Çanakkale, Turquía (Türkiye), 17100
        • Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

The population consisted of 115 individuals who applied to the hemodialysis unit of a research and practice hospital located in a city centre for hemodialysis treatment between July and October 2024. No sample selection was performed, and 82 (71.30%) patients on hemodialysis who met the inclusion criteria of the research were included in the sample.

Descripción

Inclusion Criteria:

  • being 18 years of age or older,
  • receiving HD treatment three or four times a week for at least 6 months,
  • having no hearing, visual, or speech impairment,
  • having no diagnosis of malignancy,
  • performing self-oral care,

Exclusion Criteria:

  • Patients who refused to participate in the study,
  • did not meet the inclusion criteria,
  • did not consent to an oral examination,

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: OTHER
  • Perspectivas temporales: OTHER

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
experimental group

Experimental: arm description experimental Arm Description: The socio-demographic and descriptive characteristics and disease adaptation levels included in the survey form were answered through face-to-face interviews. Participants' oral health was assessed. Oral care education was provided. Disease adaptation levels and oral health were assessed one week after the education.

After the pre-test application, one-on-one oral care education, lasting an average of 15 minutes, was conducted for each participant. The content of the education included: oral health in adults; the consequences of poor oral hygiene; points to consider for oral health; demonstration of the brushing technique; coping with care-resistant behaviors; and how to use the oral health reminder card and checklist.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Adaptation to Chronic Illness Scale
Periodo de tiempo: one weeks

The scale comprises 25 items across three subdomains, including physical, social, and psychological adjustment. The scale is designed as a 5-point Likert scale (with 1 = Strongly Disagree and 5 = Completely Agree). Items 5, 6, 12, 17, 19, 20, 24, and 25 are reverse scored. Maximum score that can be obtained from the scale is 125. Higher scores from the subdomains or the entire scale are indicative of the fact that the patients' level of adaptation to the disease is also high. The Cronbach's Alpha value of the scale is 0.88 for the entire scale.

one weeks
Oral Assessment Guide
Periodo de tiempo: one weeks

The guide allows for the assessment of voice, swallowing, lips, tongue, saliva, mucous membrane, gums, and teeth/dentures. The OAG supports the creation of an oral care protocol for patients with impaired oral mucous membranes. Each change related to oral health is scored between 1 and 3 points, and these scores are summed to obtain the total score. Scores obtainable from the OAG range from 8 to 24. A score between 8 and 14 indicates a "risk of impairment in the oral mucous membrane," while a score between 14 and 24 indicates "impairment in the oral mucous membrane." According to the OAG, a low score indicates good oral health, whereas high scores suggest poor oral health. A light source and a tongue depressor for each participant were used when evaluating oral health.

one weeks
Oral Health Reminder Card
Periodo de tiempo: one weeks

The card contains a total of 10 items regarding what should be paid attention to in daily oral health and was prepared based on the literature. The reminder cards were 10x15 cm in size, and participants were asked to place these cards somewhere visible in their homes. The reminder cards were not taken back.

one weeks
Oral Health Checklist
Periodo de tiempo: one weeks

This form contains the items listed on the Oral Health Reminder Card. Participants were asked to implement the items on the checklist and mark them as applied. Participants had the opportunity to evaluate whether they performed the oral health items every day over a one-week period.

one weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: SEVDA ATEŞ, Associate Professor, Çanakkale Onsekiz Mart University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

3 de junio de 2024

Finalización primaria (Actual)

3 de julio de 2024

Finalización del estudio (Actual)

3 de octubre de 2024

Fechas de registro del estudio

Enviado por primera vez

5 de marzo de 2026

Primero enviado que cumplió con los criterios de control de calidad

5 de marzo de 2026

Publicado por primera vez (Actual)

10 de marzo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

12 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Because patient data should not be shared during the ethics committee approval process.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir